Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40-Reference-Cited by-同舟云学术

Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40

Published:2005-07 Issue:3 Volume:14 Page:272-281
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

ARDERN-JONES A.,KENEN R.,EELES R.

Publisher

Wiley

Subject

Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2354.2005.00574.x/fullpdf

Reference25 articles.

1. The pathology of inherited breast cancer

2. Nuance, Complexity, and Context: Qualitative Methods in Genetic Counseling Research

3. Information, support, and communication needs of women with a family history of breast cancer

4. Communication ofBRCA1 andBRCA2 results to at-risk relatives: A cancer risk assessment program's experience

5. D.M. Eccles (2003 ) Abstract 'Management Choices in Hereditary Breast Cancer' presented at the Breast Cancer Linkage Consortium (BCLC) and the International Collaborative Group on Familial Breast and Ovarian Cancer 14th General Meeting. Madrid.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychosocial experiences and outcomes for individuals with breast cancer after mainstream genetic testing;2024-08-22

2. Screening and Testing for Homologous Recombination Repair Deficiency (HRD) in Breast Cancer: an Overview of the Current Global Landscape;Current Oncology Reports;2024-06-01

3. Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy;European Journal of Surgical Oncology;2024-06

4. Factors associated with adherence to BRCA1/2 mutation testing after oncogenetic counseling in long-surviving patients with a previous diagnosis of breast or ovarian cancer;Journal of Community Genetics;2023-09-19

5. The BRCA1/2 Previvor Information Journey: Understanding What Helps or Hinders;Health Communication;2023-08-25